✨ Free AI Report
Hualan Biological Engineering Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Hualan Biological Engineering Inc.
Company Research

Hualan Biological Engineering Inc.: Business Overview, Financials & Competitive Analysis

Hualan Biological Engineering is a leading Chinese biopharmaceutical company specializing in plasma-derived products, vaccines, and recombinant biologics. Founded in 1992 and listed on the Shenzhen Stock Exchange in 2...

Analyst-debate audio for Hualan Biological Engineering Inc.

AskCyborg analysts argue the bull and bear cases for Hualan Biological Engineering Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
6/ 10Solid

Cyborg Score thesis

Established Chinese biopharmaceutical leader with strategic state backing and stable market position, suitable for investors...

Read the full analyst-debate transcript →
Industry Biopharmaceuticals - Plasma Products & Vaccines
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Hualan Biological Engineering Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Hualan Biological Engineering Inc. Overview

Pro stress-test →

Hualan Biological Engineering is a leading Chinese biopharmaceutical company specializing in plasma-derived products, vaccines, and recombinant biologics. Founded in 1992 and listed on the Shenzhen Stock Exchange in 2007, the company has established itself as a national high-tech enterprise with a comprehensive portfolio spanning blood products, viral vaccines, and genetic engineering products.

Strategic Profile

Pro stress-test →

The company holds a strong market position in China's biopharmaceutical sector, particularly in plasma products and vaccines. With reported market capitalization around 71.6 billion CNY and revenue trends in the multi-billion CNY range, Hualan benefits from China's growing healthcare demand and government support for domestic biopharmaceutical manufacturers. The company operates with institutional backing and maintains alignment with state-owned pharmaceutical enterprises, positioning it as a strategically important player in China's healthcare ecosystem.

Competitive Landscape

Pro stress-test →

Hualan competes within China's biopharmaceutical sector against other plasma product and vaccine manufacturers. The company's ownership ties to China National Pharmaceutical Group Corporation and state backing provide competitive advantages in procurement and regulatory approval. Main competitors include other Chinese plasma producers and vaccine manufacturers operating in comparable therapeutic areas, though Hualan's market share in animal vaccines (20%+ by 2015) demonstrates sectoral strength.

Industry Context

Hualan Biological Engineering Inc. operates in Biopharmaceuticals - Plasma Products & Vaccines.

Key facts

Founded: 1992 · Headquarters: Lanzhou, China · Revenue: ~1.58B CNY (latest quarter, unaudited) · Market cap: 71.6B CNY (9.27B EUR)

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Hualan Biological Engineering Inc..

  • Diversified product portfolio across plasma products, human vaccines (including influenza and hepatitis B), and recombinant therapeutics reduces reliance on single revenue stream
  • Recent quarterly revenue of 1.58 billion CNY fell short of 2.11 billion CNY estimates, indicating execution challenges and market headwinds
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • Feb 2025Stock performance with 18% gain over three-month period indicates recent investor confidence
  • Q4 2025Quarterly revenue of 1.58B CNY missed expectations of 2.11B CNY, showing margin pressure
  • +1 moreTrack every material event for Hualan Biological Engineering Inc. as it happens. Explore monitoring →
Get alerted when Hualan Biological Engineering Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Plasma Products & VaccinesState-owned competitor in plasma and vaccine manufacturing→Blood ProductsRegional competitors in immunoglobulins and coagulation factors→Human VaccinesCompetitors in influenza, hepatitis, and meningococcal vaccines→

Compare Hualan Biological Engineering Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Hualan Biological Engineering Inc. operates in Biopharmaceuticals - Plasma Products & Vaccines. See how the rest of the sector scores on the Cyborg framework.

Browse Biopharmaceuticals - Plasma Products & Vaccines research →
NEW · MCP server

Ask your AI assistant about Hualan Biological Engineering Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Hualan Biological Engineering Inc. and its top competitor on Cyborg Score”
“What did Hualan Biological Engineering Inc. do this quarter?”
“Is Hualan Biological Engineering Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Hualan Biological Engineering Inc. do?+
Hualan Biological Engineering is a leading Chinese biopharmaceutical company specializing in plasma-derived products, vaccines, and recombinant biologics. Founded in 1992 and listed on the Shenzhen Stock Exchange in 2...
What is Hualan Biological Engineering Inc.'s Cyborg Score?+
Hualan Biological Engineering Inc. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Hualan Biological Engineering Inc.'s main competitors?+
Named competitors include Plasma Products & Vaccines, Blood Products, Human Vaccines. The full competitive landscape is in the AskCyborg report.
How can I get the full Hualan Biological Engineering Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Hualan Biological Engineering Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Hualan Biological Engineering Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.